AI assistant
CLOROX CO /DE/ — Director's Dealing 2012
Oct 10, 2012
30403_dirs_2012-10-10_c016cbbb-eb26-4630-94c6-96547b29937a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2012-10-08
Reporting Person: DELKER WAYNE L (SVP-Chief Innovation Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-10-08 | Common Stock | M | 13200.0000 | $53.8800 | Acquired | 32649.0000 | Direct |
| 2012-10-08 | Common Stock | S | 12699.0000 | $74.0199 | Disposed | 19950.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-10-08 | Stock Option (Right to Buy) | $53.8800 | M | 13200.0000 | Disposed | 2014-09-15 | Common Stock (13200.0000) | Direct |
Footnotes
F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: This transaction was executed in multiple trades at prices ranging from $73.90 to $74.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.